25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy

J Glaucoma. 2007 Jan;16(1):169-70. doi: 10.1097/01.ijg.0000212291.85669.21.

Abstract

Purpose: Secondary glaucoma and vitreous opacity with amyloid fibrils are the 2 major ocular complications of familial amyloid polyneuropathy (FAP). We investigated the feasibility of 25-gauge vitrectomy in excising the opaque vitreous into eyes that had already undergone trabeculectomy.

Methods: For the purpose of vision recovery, 25-gauge vitrectomy was performed in 2 eyes with vitreous amyloidosis. Both eyes had undergone trabeculectomy to treat glaucoma secondary to FAP. The survival of the filtration bleb after 25-gauge vitrectomy was also evaluated.

Results: Vision improved dramatically on the next day after the 25-gauge vitrectomy that causes minimal damage to the eye. No apparent complications including failure of the filtration bleb have been observed throughout the follow-up period of 6 months.

Conclusions: 25-gauge vitrectomy has a potential to become a therapy of choice to excise opaque vitreous with amyloid fibrils in FAP, especially in the glaucomatous eyes that have already undergone trabeculectomy.

Publication types

  • Case Reports

MeSH terms

  • Amyloid / metabolism
  • Amyloid Neuropathies, Familial / complications
  • Amyloid Neuropathies, Familial / metabolism
  • Amyloid Neuropathies, Familial / surgery*
  • Eye Diseases / etiology
  • Eye Diseases / metabolism
  • Eye Diseases / surgery*
  • Female
  • Glaucoma / etiology
  • Glaucoma / surgery
  • Humans
  • Middle Aged
  • Trabeculectomy
  • Vitrectomy / methods*
  • Vitreous Body / metabolism
  • Vitreous Body / pathology
  • Vitreous Body / surgery*

Substances

  • Amyloid